Peter Attia· MD
in the 1990s the nia put i think 100 million dollars into developing biomarkers of aging and it came out with nothing but that may have been that we just didn't have the right tools at that point
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in the 1990s the nia put i think 100 million dollars into developing biomarkers of aging and it came out with nothing but that may have been that we just didn't have the right tools at that point
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.